Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice.
Author | |
---|---|
Abstract | :
Binge eating disorder (BED) is the most common eating disorder and was newly recognized in 2013 in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). BED is frequently associated with obesity and the metabolic syndrome, as well as with other psychiatric diseases, such as mood (49%), anxiety (41%), and substance use (22%) disorders. BED is highly prevalent and carries a high burden of mental and physical illness and disability. However, BED is frequently under-recognized and under-treated. |
Year of Publication | :
2019
|
Journal | :
Expert opinion on pharmacotherapy
|
Volume | :
20
|
Issue | :
6
|
Number of Pages | :
679-690
|
ISSN Number | :
1465-6566
|
URL | :
http://www.tandfonline.com/doi/full/10.1080/14656566.2019.1571041
|
DOI | :
10.1080/14656566.2019.1571041
|
Short Title | :
Expert Opin Pharmacother
|
Download citation |